VIRS
Pacer BioThreat Strategy ETF
VIRS
VIRS
Delisted
VIRS was delisted on the 10th of October, 2024.
6 hedge funds and large institutions have $3.21M invested in Pacer BioThreat Strategy ETF in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1.93M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$703K |
| 3 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$11K |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$6.91K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Osaic Holdings
Scottsdale,
Arizona
| $2.09M | +$1.93M | +55,530 | +1,227% |
|
|
2
Royal Bank of Canada
Toronto,
Ontario, Canada
| $778K | +$703K | +20,202 | +942% |
|
3
Cambridge Investment Research Advisors
Fairfield,
Iowa
| $271K | – | – | – |
|
|
LF
4
Lee Financial
Dallas,
Texas
| $51K | – | – | – |
|
|
AA
5
Ancora Advisors
Cleveland,
Ohio
| $11K | +$11K | +203 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| $4K | -$6.91K | -221 | -63% |
|